Targeting autotaxin impacts disease advance in the SOD1‐G93A mouse model of amyotrophic lateral sclerosis

A preclinical strategy to broaden the search of potentially effective treatments in amyotrophic lateral sclerosis (ALS) relies on identifying factors controlling motor neuron (MN) excitability. These partners might be part of still unknown pathogenic pathways and/or useful for the design of new inte...

Descripción completa

Detalles Bibliográficos
Autores principales: Gento‐Caro, Ángela, Vilches‐Herrando, Esther, Portillo, Federico, González‐Forero, David, Moreno‐López, Bernardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9048519/
https://www.ncbi.nlm.nih.gov/pubmed/34585475
http://dx.doi.org/10.1111/bpa.13022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9048519/
https://www.ncbi.nlm.nih.gov/pubmed/34585475
http://dx.doi.org/10.1111/bpa.13022

Ejemplares similares